Top

Published in:

01-12-2023 | Secukinumab | Case report

Secukinumab

Drug resistance: case report

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

…

Chen Y, et al. Transition from secukinumab to adalimumab in COVID-19-induced psoriasis flare-up treatment: A case report. Clinical Case Reports 11: no pagination, No. 10, Oct 2023. Available from: URL: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

Title: Secukinumab
Drug resistance: case report
Publication date: 01-12-2023
Publisher: Springer International Publishing
Keywords: Secukinumab
Vulgar Psoriasis
Atorvastatin
Adalimumab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-51242-7